Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $108.8000 (7.06%) ($100.2500 - $108.8000) on Sun. Nov. 10, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.73% (three month average) | RSI | 52 | Latest Price | $108.8000(7.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting LGND price | LGND will decline at least -1.365% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.365% (StdDev 2.73%) | Hourly BBV | 0 () | Intraday Trend | 7.7% | | | |
|
Resistance Level | $108.83 | 5 Day Moving Average | $106.93(1.75%) | 10 Day Moving Average | $109.11(-0.28%) | 20 Day Moving Average | $108.83(-0.03%) | To recent high | -4.2% | To recent low | 26.1% | Market Cap | $N/A | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |